Rituximab-induced accelerated cryoprecipitation in hepatitis C virus-associated mixed cryoglobulinemia has parallels with intravenous immunoglobulin-induced immune complex deposition in mixed cryoglobulinemia: comment on the article by Sène et al.
Misbah
Siraj A
SA
D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D003449:Cryoglobulinemia / Q000139:chemically induced* / Q000276:immunology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D007155:Immunologic Factors / Q000009:adverse effects*; D010265:Paraproteinemias / Q000276:immunology; D012217:Rheumatoid Factor / Q000276:immunology; D000069283:Rituximab; D012713:Serum Sickness / Q000139:chemically induced / Q000276:immunology; D056647:Systemic Vasculitis / Q000139:chemically induced* / Q000276:immunology
D058846:Antibodies, Monoclonal, Murine-Derived; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D000069283:Rituximab; D012217:Rheumatoid Factor